The Science of Prevention: Novel Strategies for and New Insights Into Central Nervous System Prophylaxis in Patients With CancerGLANTZ, Michael; RECHT, Lawrence.Seminars in oncology. 2009, Vol 36, Num 4, issn 0093-7754, 77 p., SUP2Conference Proceedings

Treatment Modalities for Leptomeningeal MetastasesSHAPIRO, William R; JOHANSON, Conrad E; BOOGERD, Willem et al.Seminars in oncology. 2009, Vol 36, Num 4, issn 0093-7754, S46-S54, SUP2Conference Paper

Diagnostic Tools for Neoplastic Meningitis: Detecting Disease, Identifying Patient Risk, and Determining Benefit of TreatmentCHAMBERLAIN, Marc C; GLANTZ, Michael; GROVES, Morris D et al.Seminars in oncology. 2009, Vol 36, Num 4, issn 0093-7754, S35-S45, SUP2Conference Paper

Central Nervous System Disease in Hematologic Malignancies: Historical Perspective and Practical ApplicationsPUI, Ching-Hon; THIEL, Eckhard.Seminars in oncology. 2009, Vol 36, Num 4, issn 0093-7754, S2-S16, SUP2Conference Paper

The Role of Intra-cerebrospinal Fluid Treatment and Prophylaxis in Patients With Solid TumorsSOFFIETTI, Riccardo; AKERLEY, Wallace; JENSEN, Randy L et al.Seminars in oncology. 2009, Vol 36, Num 4, issn 0093-7754, S55-S68, SUP2Conference Paper

Understanding the Origins of Gliomas and Developing Novel Therapies: Cerebrospinal Fluid and Subventricular Zone InterplayGLANTZ, Michael; KESARI, Santosh; RECHT, Lawrence et al.Seminars in oncology. 2009, Vol 36, Num 4, issn 0093-7754, S17-S24, SUP2Conference Paper

Statistical and Trial Design Considerations in Central Nervous System Prophylaxis StudiesSMITH, Jennifer A; GLANTZ, Michael.Seminars in oncology. 2009, Vol 36, Num 4, issn 0093-7754, S69-S76, SUP2Conference Paper

Should Intra-cerebrospinal Fluid Prophylaxis Be Part of Initial Therapy for Patients With Non-Hodgkin Lymphoma: What We Know, and How We Can Find Out MoreHERRLINGER, Ulrich; GLANTZ, Michael; SCHLEGEL, Uwe et al.Seminars in oncology. 2009, Vol 36, Num 4, issn 0093-7754, S25-S34, SUP2Conference Paper